American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Launched by UNIVERSITY OF NEW MEXICO · Dec 2, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study) is looking to better understand chronic kidney disease (CKD) and heart diseases in American Indian communities. The study will involve 500 participants and aims to identify risk factors that could lead to the progression of kidney disease. This research builds on previous studies about kidney and heart health and will use updated methods to measure health outcomes.
To be eligible for the study, participants should be aged between 76 and 92 years and have certain kidney function levels. Specifically, they must have a specific type of kidney function test result indicating mild to moderate kidney impairment. However, individuals with severe kidney disease, recent kidney transplants, certain types of cancer, or those who are currently pregnant or incarcerated will not be eligible. Participants can expect to share their health information and undergo tests that will help researchers learn more about kidney and heart health in their community. This study is important because it focuses on the unique health challenges faced by American Indians and seeks to improve care and outcomes for these populations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Glomerular Filtration Rate (GFR): eGFR of =\>61\<80 and microalbuminuria \> 30 or eGRF of =\<60 (no microalbuminuria required).
- Exclusion Criteria:
- • 1. Unable or unwilling to provide informed consent
- • 2. life expectancy \<3 years;
- • 3. institutionalized subjects;
- • 4. End stage renal disease or renal transplant;
- • 5. renal cancer;
- • 6. myeloma;
- • 7. immunosuppression;
- • 8. Polycystic kidney disease;
- • 9. participation in any clinical trial,
- • 10. current pregnancy
- • 11. current incarceration.
- • 12. Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.
About University Of New Mexico
The University of New Mexico (UNM) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a robust commitment to improving patient outcomes, UNM leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research across various fields. The university fosters collaboration among researchers, clinicians, and community partners, ensuring that its trials are not only scientifically rigorous but also responsive to the needs of diverse populations. UNM is dedicated to translating research findings into practical applications, ultimately contributing to the enhancement of medical knowledge and the quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phoenix, Arizona, United States
Albuquerque, New Mexico, United States
Black Rock, New Mexico, United States
Patients applied
Trial Officials
Mark L Unruh, MD
Principal Investigator
University of New Mexico
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials